Yeap!
There are two cell therapy companies that went strange.
PSTI just launched Phase II and there is still a long way to go. The stock
climbed since July.
ASTM on the contrary. With a promising Phase II result and start of Phase
III, this stock is at 52 week low.
I am in for ASTM for 2000 share. lol